ICD-10-CM/PCS MS-DRG v36.0 Definitions Manual |
||||
Skip to content |
MDC 11 Diseases & Disorders of the Kidney & Urinary Tract |
Other Kidney and Urinary Tract Procedures |
Page 6 of 6 |
OPERATING ROOM PROCEDURES (continued)
00HE0MZ 03VN4DZ 047J376 057C3D1 0GTM0ZZ 0WJP4ZZ
0WJP4ZZ | Inspection of Gastrointestinal Tract, Percutaneous Endoscopic Approach |
0WJQ0ZZ | Inspection of Respiratory Tract, Open Approach |
0WJR0ZZ | Inspection of Genitourinary Tract, Open Approach |
0WJR4ZZ | Inspection of Genitourinary Tract, Percutaneous Endoscopic Approach |
0Y350ZZ | Control Bleeding in Right Inguinal Region, Open Approach |
0Y353ZZ | Control Bleeding in Right Inguinal Region, Percutaneous Approach |
0Y354ZZ | Control Bleeding in Right Inguinal Region, Percutaneous Endoscopic Approach |
0Y360ZZ | Control Bleeding in Left Inguinal Region, Open Approach |
0Y363ZZ | Control Bleeding in Left Inguinal Region, Percutaneous Approach |
0Y364ZZ | Control Bleeding in Left Inguinal Region, Percutaneous Endoscopic Approach |
0Y9500Z | Drainage of Right Inguinal Region with Drainage Device, Open Approach |
0Y950ZZ | Drainage of Right Inguinal Region, Open Approach |
0Y9540Z | Drainage of Right Inguinal Region with Drainage Device, Percutaneous Endoscopic Approach |
0Y954ZZ | Drainage of Right Inguinal Region, Percutaneous Endoscopic Approach |
0Y9600Z | Drainage of Left Inguinal Region with Drainage Device, Open Approach |
0Y960ZZ | Drainage of Left Inguinal Region, Open Approach |
0Y9640Z | Drainage of Left Inguinal Region with Drainage Device, Percutaneous Endoscopic Approach |
0Y964ZZ | Drainage of Left Inguinal Region, Percutaneous Endoscopic Approach |
0YJ50ZZ | Inspection of Right Inguinal Region, Open Approach |
0YJ60ZZ | Inspection of Left Inguinal Region, Open Approach |
0YJ70ZZ | Inspection of Right Femoral Region, Open Approach |
0YJA0ZZ | Inspection of Bilateral Inguinal Region, Open Approach |
OR PRINCIPAL DIAGNOSIS
E883 | Tumor lysis syndrome |
I120 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
I129 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I1311 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
N170 | Acute kidney failure with tubular necrosis |
N171 | Acute kidney failure with acute cortical necrosis |
N172 | Acute kidney failure with medullary necrosis |
N178 | Other acute kidney failure |
N179 | Acute kidney failure, unspecified |
N181 | Chronic kidney disease, stage 1 |
N182 | Chronic kidney disease, stage 2 (mild) |
N183 | Chronic kidney disease, stage 3 (moderate) |
N184 | Chronic kidney disease, stage 4 (severe) |
N185 | Chronic kidney disease, stage 5 |
N186 | End stage renal disease |
N189 | Chronic kidney disease, unspecified |
N19 | Unspecified kidney failure |
R34 | Anuria and oliguria |
T795XXA | Traumatic anuria, initial encounter |
AND NON-OPERATING ROOM PROCEDURES
0JH60XZ* | Insertion of Tunneled Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Open Approach |
0JH63WZ* | Insertion of Totally Implantable Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JH63XZ* | Insertion of Tunneled Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JH80XZ* | Insertion of Tunneled Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Open Approach |
0JH83WZ* | Insertion of Totally Implantable Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JH83XZ* | Insertion of Tunneled Vascular Access Device into Abdomen Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHD0XZ* | Insertion of Tunneled Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Open Approach |
0JHD3WZ* | Insertion of Totally Implantable Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHD3XZ* | Insertion of Tunneled Vascular Access Device into Right Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHF0XZ* | Insertion of Tunneled Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Open Approach |
0JHF3WZ* | Insertion of Totally Implantable Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHF3XZ* | Insertion of Tunneled Vascular Access Device into Left Upper Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHG0XZ* | Insertion of Tunneled Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Open Approach |
0JHG3WZ* | Insertion of Totally Implantable Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHG3XZ* | Insertion of Tunneled Vascular Access Device into Right Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHH0XZ* | Insertion of Tunneled Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Open Approach |
0JHH3WZ* | Insertion of Totally Implantable Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHH3XZ* | Insertion of Tunneled Vascular Access Device into Left Lower Arm Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHL0XZ* | Insertion of Tunneled Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Open Approach |
0JHL3WZ* | Insertion of Totally Implantable Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHL3XZ* | Insertion of Tunneled Vascular Access Device into Right Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHM0XZ* | Insertion of Tunneled Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Open Approach |
0JHM3WZ* | Insertion of Totally Implantable Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHM3XZ* | Insertion of Tunneled Vascular Access Device into Left Upper Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHN0XZ* | Insertion of Tunneled Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach |
0JHN3WZ* | Insertion of Totally Implantable Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHN3XZ* | Insertion of Tunneled Vascular Access Device into Right Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHP0XZ* | Insertion of Tunneled Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Open Approach |
0JHP3WZ* | Insertion of Totally Implantable Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
0JHP3XZ* | Insertion of Tunneled Vascular Access Device into Left Lower Leg Subcutaneous Tissue and Fascia, Percutaneous Approach |
OR PRINCIPAL DIAGNOSIS
E1021 | Type 1 diabetes mellitus with diabetic nephropathy |
E1022 | Type 1 diabetes mellitus with diabetic chronic kidney disease |
E1029 | Type 1 diabetes mellitus with other diabetic kidney complication |
AND NON-OPERATING ROOM PROCEDURES
3E030U0* | Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach |
3E030U1* | Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach |
3E033U0* | Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach |
3E033U1* | Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach |
3E0J3U0* | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach |
3E0J3U1* | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach |
3E0J7U0* | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening |
3E0J7U1* | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening |
3E0J8U0* | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic |
3E0J8U1* | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic |
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 04 Oct 2018 16:21:08 CMS, code-revision=145, description-revision=1114 |